Stocknews
FTSE Bursa Malaysia KLCI (^KLSE) 1,646.53 14.83 (0.90%)
updated at: Wed, 09 Dec 2020, 05:25PM MYT

CGS-CIMB Research retains Add for Duopharma, lower TP of RM1.90

DPHARMA
CIMB
DPHARMA
Original Source From TheStar Publish at Fri, 14 Feb 2020, 08:58AM

Duopharma Biotech’s FY19 revenue rose to RM576.5m (+15.6% yoy). FY19 core net profit grew 8.3% yoy to RM63m. This excluded one-off losses of RM7.8m from inventory write-offs (RM7.6m) and forex (RM0.2m).

Top Participation View More
updated at: Fri, 29 May 2020 MYT
Participation (%)
Bought (MYR)
Sold (MYR)
Net
Foreign
( 24,36 % )
2.31 B 2.23 B 77.37 M
Local Institution
( 39,38 % )
3.66 B 3.67 B 0.00 B
Local Retail
( 36,26 % )
3.34 B 3.41 B -0.07 B